Clinical Study
Cushing’s Disease: The Relevance of a Combined Dexamethasone Desmopressin Test as a Component of Postoperative Hormonal Evaluation
Table 2
Comparison of ACTH (pg/mL) and cortisol levels (μg/dL) in the remission and uncured subgroups following CDDT.
| | Remission () | Persistent CD () | value | | Mean ± SD | Median | Range | Mean ± SD | Median | Range |
| Cortisol (μg/dL) | | | | | | | | 0′ | 1.27 ± 0.57 | 1.0 | 1.0–2.9 | 7.72 ± 6.37 | 4.8 | 2.4–25.7 | <0.001 | 15′ | 2.08 ± 3.32 | 1.0 | 1.0–14.0 | 16.43 ± 7.80 | 16.1 | 3.1–29.6 | <0.001 | 30′ | 2.15 ± 3.52 | 1.1 | 1.0–14.8 | 20.61 ± 8.72 | 22.9 | 3.0–32.7 | <0.001 | 60′ | 1.86 ± 2.49 | 1.0 | 1.0–10.7 | 22.22 ± 9.96 | 24.7 | 2.9–37.8 | <0.001 | 90′ | 1.68 ± 1.80 | 1.0 | 1.0–8.0 | 20.86 ± 10.16 | 22.3 | 2.5–35.2 | <0.001 | 120′ | 1.55 ± 1.55 | 1.0 | 1.0–7.0 | 18.69 ± 10.25 | 18.4 | 2.7–36.7 | <0.001 | ACTH (pg/mL) | | | | | | | | 0′ | 3.54 ± 3.73 | 3.0 | 1.0–15.0 | 34.31 ± 29.54 | 19.0 | 9.0–96.0 | <0.001 | 15′ | 8.56 ± 9.86 | 5.0 | 2.0–36.0 | 185.62 ± 297.56 | 91.0 | 20.0–1135.0 | <0.001 | 30′ | 6.73 ± 7.34 | 4.0 | 1.0–25.0 | 162.46 ± 232.92 | 95.0 | 22.0–900.0 | <0.001 | 60′ | 4.70 ± 5.28 | 3.0 | 0.6–19.0 | 101.15 ± 128.60 | 73.0 | 16.0–502.0 | <0.001 | 90′ | 3.77 ± 4.01 | 2.0 | 0.4–16.0 | 85.00 ± 115.38 | 50.0 | 11.0–441.0 | <0.001 | 120′ | 3.29 ± 3.20 | 2.0 | 1.0–13.0 | 72.69 ± 104.18 | 34.0 | 7.0–395.0 | <0.001 |
|
|